Quarterly report pursuant to Section 13 or 15(d)

REVENUE (Details Narrative)

v3.22.2.2
REVENUE (Details Narrative) - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
[custom:UnamortizedCommissionCostsAbstract]    
Deferred commissions $ 692 $ 922
Group Purchasing Services [Member]    
[custom:ContractAssetGPOAbstract]    
Estimated recognition period for remaining performance obligations 3 months  
Unpaid earned revenue $ 500  
Revenue Cycle Management [Member]    
[custom:ContractAssetMedicalBillingAbstract]    
Remaining revenue obligations $ 3,900